HOXB13 and head and neck cancer: Given that NPC is classified under head and neck cancers, the expression level of HOXB13 in head and neck cancer was initially examined using the TCGA database, which revealed significantly higher HOXB13 expression in tumor tissues compared to normal tissues (Fig. 1A).